April is Testicular Cancer, Esophageal Cancer and Head & Neck Cancer Awareness Month

April is Testicular Cancer, Esophageal Cancer and Head & Neck Cancer Awareness Month

This Weekly’s Hot Topics

  • Disparities in Clinical Trials webinar this Thursday MOASC News/MOASC Programs
  • Medi-Cal Rx monthly bulletin has been published California News
  • New changes in HCPCS drug codes Medicare News/ CMS News
  • ICER report on novel agents to prevent chemotherapy-induced neutropenia National News

Medi-Cal Rx monthly bulletin for April 2022 has been published. Highlights are: Changes to the Contract Drugs List (CDL); Changes to the Contract Drugs List (CDL) – Over-the-Counter Drugs; Changes to the Contract Drugs List (CDL) – Authorized Drug Manufacturer Labeler Codes; Updates to the Medi-Cal Rx Provider Manual; Claim Edit Prescriber Enrollment; Claim Edit Prescriber Enrollment; Medi-Cal Rx Drug Lookup Tool and Contract Drugs List; Medi-Cal Rx Provider Portal Troubleshooting and Support. To read more click here and go to California News.

April 1 brings new changes in HCPCS drug codes, Medicare drug allowables, HOPPS, “buy & bill,” and Sequestration returns to minus 1%. To read more click here and go to Medicare News/CMS News.

ICER published evidence report on novel agents to prevent chemotherapy-induced neutropenia and other myelosuppressive effects. To read more click here and go to National News.

Anthem Blue Cross is the latest payor to halt the reimbursement of consultation services. Effective January 1, 2022, Anthem is no longer reimbursing for inpatient and outpatient consultation CPT codes 99241-99245 and 99251-99255 for its for commercial insurance products. Instead, providers will need to bill utilizing the appropriate evaluation and management (E/M) procedure code that describes the office visit, hospital care, nursing facility care, home service or domiciliary/rest home care. To read more click here and go to National News.

To read the full edition of the California Oncology Weekly Newsletter, click on the date below.

 April 5, 2022



No comments have been posted yet.